Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate

Pharmacotherapy

Volumn 24, Issue 8, 2004, Pages 1089-1094

  Guo, Yi ^a   Fung, Horatio B ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Didanosine; Human immunodeficiency virus; Lactic acidosis; Tenofovir disoproxil fumarate

Indexed keywords

ABACAVIR; BETA LACTAMASE INHIBITOR; BICARBONATE; DIDANOSINE; FRESH FROZEN PLASMA; HYPERTENSIVE FACTOR; INDINAVIR; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR DISOPROXIL; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; APPETITE DISORDER; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG FATALITY; DRUG TOLERABILITY; DYSPNEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; MALE; MUSCLE WEAKNESS; NAUSEA; SIDE EFFECT; VOMITING; WEIGHT REDUCTION;

ACIDOSIS, LACTIC; ADENINE; ANTI-HIV AGENTS; AREA UNDER CURVE; COMORBIDITY; DIDANOSINE; DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; HIV INFECTIONS; HUMANS; LACTATES; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 3543075654     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.11.1089.36138     Document Type: Article

References (18)

1. Falco V, Crespo M, Ribera E. Lactic acidosis related to nucleoside therapy in HIV-infected patients. Expert Opin Pharmacother 2003;4:1321-9.
2. Moyle GJ, Datta D, Mandalia S, et al. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS 2002;16:1341-9.
3. Gilead Sciences, Inc. Viread (tenofovir disoproxil fumarate) package insert. Foster City, CA; 2003.
4. Murphy MD, O'Hearn M, Chou S. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Clin Infect Dis 2003;36:1082-5.
5. Rivas P, Polo J, Gorgolas M, Gernandez-Guerrero ML. Drug points: fatal lactic acidosis associated with tenofovir. BMJ 2003;327:711.
6. Flaherty J, Wolf J, Sayre J, et al. Coadministration of tenofovir DF and didanosine: a pharmacokinetic and safety evaluation. Presented as a poster at the 41st interscience conference on antimicrobial agents and chemotherapy, Chicago, 1L, September 22-25, 2001.
7. Bristol-Myers Squibb Co. Videx EC (didanosine) package insert. Princeton, NJ; 2003.
8. Gilead Sciences, Inc. Viread (tenofovir disoproxil fumarate) package insert. Foster City, CA; 2001.
9. Gallant J, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis 2003;37:944-50.
10. Fung HB, Stone EA, Piacenti FJ. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. Clin Ther 2002;24:1515-48.
11. Robbins B, Wilcox C, Fridland A, Rodman JH. Metabolism of tenofovir and didanosine in quiescent or stimulated human peripheral blood mononuclear cells. Pharmacotherapy 2003;23:695-701.
12. Fulco PP, Kirian MA. Effect of tenofovir on didanosine absorption in patients with HIV. Ann Pharmacother 2003;37:1325-8.
13. Arenas-Pinto A, Grant AD, Edwards S, Weller IV. Lactic acidosis in HIV infected patients: a systematic review of published cases. Sex Transm Infect 2003;79:340-4.
14. Cihlar T, Birkus G, Greenwalt DE, Hitchcock MJ. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. Antivir Res 2002;54:37-45.
15. Brinkman K, Hofstede HJ, Burger DM, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998;12:1735-44.
16. Walker UA, Bauerle J, Laguno M, et al. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine or zalcitabine. Hepatology 2004;39:311-17.
17. Lonergan JT, Havlir D, Behling C, et al. Hyperlactatemia in 20 patients receiving NRTI combination regimens. Presented at the 7th conference on retroviruses and opportunistic infections, San Francisco, CA, January 30-February 4, 2000:
18. Mokrzycki MH, Harris C, May H, et al. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 2000;30:198-200.